High dose busulfan, cyclophosphamide and etoposide as a conditioning regimen for autologous progenitor cell transplantation in patients with multiple myeloma.

被引：0
|
作者：
Cogle, CR [1 ]
Moreb, JS [1 ]
Belanger, GL [1 ]
Leather, HL [1 ]
Boyette, RM [1 ]
Finiewicz, K [1 ]
Khan, SA [1 ]
Reddy, VS [1 ]
Wingard, JR [1 ]
机构：
[1] Univ Florida, Shands Canc Ctr, Gainesville, FL USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5343
引用
收藏
页码：368B / 368B
页数：1
相关论文
共 50 条
  • [31] High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
    Cavo, M
    Bandini, G
    Benni, M
    Gozzetti, A
    Ronconi, S
    Rosti, G
    Zamagni, E
    Lemoli, RM
    Bonini, A
    Belardinelli, A
    Motta, MR
    Rizzi, S
    Tura, S
    BONE MARROW TRANSPLANTATION, 1998, 22 (01) : 27 - 32
  • [32] Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment
    Zhou, Shiyuan
    Zhai, Yingying
    Yan, Lingzhi
    Shi, Xiaolan
    Shang, Jingjing
    Wu, Depei
    Fu, Chengcheng
    Jin, Song
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [33] Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Rodriguez, Tulio E.
    Hari, Parameswaran
    Stiff, Patrick J.
    Smith, Scott E.
    Sterrenberg, Danielle
    Vesole, David H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (08) : 1391 - 1396
  • [34] Autologous stem cell transplantation with high dose melphalan conditioning regimen is safe for elderly multiple myeloma patients
    Czyz, Anna
    Szeremet, Agnieszka
    Bogucka-Fedorczuk, Aleksandra
    Majcherek, Maciej
    Rybka, Justyna
    Prajs, Iwona
    Wrobel, Tomasz
    BONE MARROW TRANSPLANTATION, 2019, 54 : 499 - 500
  • [35] High-Dose Busulfan and Melphalan as Conditioning Regimen for Autologous Peripheral Blood Progenitor Cell Transplantation in High-Risk Neuroblastoma Patients
    Molina, Blanca
    Alonso, Laura
    Gonzalez-Vicent, Marta
    Andion, Maitane
    Hernandez, Carmen
    Lassaletta, Alvaro
    Cormenzana, Maria
    Lopez-Ibor, Blanca
    Villa, Marta
    Molina, Javier
    Diaz, Miguel A.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28 (02) : 115 - 123
  • [36] Autologous haematopoietic stem cell transplantation with busulfan and etoposide as conditioning regimen for acute myelogenous leukaemia patients
    Ghavamzadeh, A.
    Alimogaddam, K.
    Khatami, F.
    Gaffari, F.
    Ashuri, A.
    Mousavi, A.
    Iravani, M.
    Bahar, B.
    Jahani, M.
    Khodabande, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S133 - S134
  • [37] Autologous haematopoietic stem cell transplantation with busulfan and etoposide as conditioning regimen for acute myelogenous leukaemia patients
    Mousavi, S.
    Alimoghaddam, K.
    khatami, F.
    Jahani, M.
    Iravani, M.
    Bahar, B.
    Khodabandeh, A.
    Jalali, A.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S381 - S382
  • [38] High-Dose Melphalan Versus Busulfan, Cyclophosphamide As Conditioning Regimens for Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
    Styler, Michael
    Crilley, Pamela Ann
    Jain, Maneesh
    Ward, Kristine
    Topolsky, David
    Cho, David
    Kim, Marc
    BLOOD, 2015, 126 (23)
  • [39] Cytoreduction and stem cell mobilization with a regimen of paclitaxel, etoposide and cyclophosphamide followed by autologous transplantation using a preparative regimen of busulfan, etoposide and cyclophosphamide for patients with advanced lymphoma
    Tutschka, PJ
    Bilgrami, SA
    Feingold, JM
    Edwards, RL
    Bona, RD
    Naqvi, B
    Clive, J
    ACTA HAEMATOLOGICA, 2001, 105 (04) : 222 - 232
  • [40] A NOVEL PREPARATORY REGIMEN INCLUDING BUSULFAN, ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR AUTOLOGOUS TRANSPLANTATION IN HODGKIN AND NON-HODGKIN LYMPHOMA AND MULTIPLE MYELOMA
    EACopelan
    BBolwell
    JLKlien
    NKapoor
    BRAvalos
    中华医学杂志(英文版), 1994, (10) : 8 - 8
12345